NCT01915173View on ClinicalTrials.gov

Response to Supplement and Placebo in GERD

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Gastroesophageal Reflux Disease (GERD)HeartburnDyspepsia
Interventions
DRUG

Supplement

Abies nigra 4C, Carbo vegetabilis 4C, Nux vomica 4C, and Robinia pseudoacacia 4C

DRUG

Placebo

Lactose tablets

BEHAVIORAL

Expanded Interview

BEHAVIORAL

Standard Interview

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT01915173 - Response to Supplement and Placebo in GERD | Biotech Hunter | Biotech Hunter